It has been further established that NAFLD could promote the expression of IL-1β, VEGF, and NOD-like receptor C4 in tumor-associated macrophages and accelerate the growth of the liver tumor [32]. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.